为研究谷胱甘肽S转移酶A1(GSTA1)在肝损伤早期诊断中的价值,本试验通过检测血清谷丙转氨酶(GPT)及肝组织指标丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GSH-Px)变化,成功复制急性酒精性肝损伤小鼠模型;通...为研究谷胱甘肽S转移酶A1(GSTA1)在肝损伤早期诊断中的价值,本试验通过检测血清谷丙转氨酶(GPT)及肝组织指标丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GSH-Px)变化,成功复制急性酒精性肝损伤小鼠模型;通过时间-效应和剂量-效应关系研究血清中GSTA1和ALT变化。结果显示,给予小鼠灌服乙醇溶液后,2 h血清中GSTA1含量变化与对照组相比差异极显著(P<0.01),而ALT活性变化在6 h才显示出一定的差异性(P<0.05);当乙醇剂量为10 m L/kg体重时,血清中GSTA1含量变化与对照组相比差异极显著(P<0.01),而当乙醇剂量达到14 m L/kg体重时,ALT活性变化与对照组相比差异极显著(P<0.01)。表明在急性酒精性肝损伤模型中,GSTA1的含量变化在肝损伤早期就可检测出来,作为肝损伤标记物,GSTA1比ALT更敏感。展开更多
The aim of the study was to investigate the hepatoprotective effects of Folium syringae(FS) extracts against ethanolinduced acute liver injury. Mice and primary hepatocytes were pretreated with FS extracts at differen...The aim of the study was to investigate the hepatoprotective effects of Folium syringae(FS) extracts against ethanolinduced acute liver injury. Mice and primary hepatocytes were pretreated with FS extracts at different dosages before ethanol administration. Transaminases, glutathione S-transferase A1 level and hepatic biochemical indices(malondialdehyde, superoxide dismutase, glutathione and glutathione peroxidase) were determined. Pretreatment with FS extracts significantly inhibited the damage caused by ethanol and the hepatoprotective effects of FS were almost similar to Silymarin that was used to treat alcoholic liver injury. GSTA1 contents in all the FS extract-treated groups were significantly different from those in the ethanol-induced acute liver injury model group(p<0.01), and similar trends were observed in transaminases and hepatic indices level both in vitro and in vivo. The results showed that FS extracts had hepatoprotective effects against ethanol-induced injury. Those effects might be related to the enhancement of antioxidant capacity of liver cells, and FS extracts could reduce the release of liver GSTA1, which contributed to improve liver detoxification.展开更多
AIM Human glutathione S-transferase A1 (GSTA1) is an important phase Ⅱ metabolizing enzyme involved in the metabolism of many therapeutic drugs and is responsible for the metabolic detoxification of numerous promutag...AIM Human glutathione S-transferase A1 (GSTA1) is an important phase Ⅱ metabolizing enzyme involved in the metabolism of many therapeutic drugs and is responsible for the metabolic detoxification of numerous promutagens and procarcinogens. The genetic polymorphism of GSTA1 has important implications for drug efficacy and cancer susceptibility. In this study, we determined the distribution of GSTA1 genetic polymorphism in Mainland Chinese. And we also investigated whether there exists the potential phenotype alterations caused by the genetic polymorphism in human. METHODS Genomic DNA was ex-tracted from peripheral blood of 140 Chinese people and 16 liver tissues obtained from non-liverish patients who underwent partial hepatectomy. And then the genotypes of human GSTA1 gene were analyzed by polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP).展开更多
文摘为研究谷胱甘肽S转移酶A1(GSTA1)在肝损伤早期诊断中的价值,本试验通过检测血清谷丙转氨酶(GPT)及肝组织指标丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、谷胱甘肽过氧化物酶(GSH-Px)变化,成功复制急性酒精性肝损伤小鼠模型;通过时间-效应和剂量-效应关系研究血清中GSTA1和ALT变化。结果显示,给予小鼠灌服乙醇溶液后,2 h血清中GSTA1含量变化与对照组相比差异极显著(P<0.01),而ALT活性变化在6 h才显示出一定的差异性(P<0.05);当乙醇剂量为10 m L/kg体重时,血清中GSTA1含量变化与对照组相比差异极显著(P<0.01),而当乙醇剂量达到14 m L/kg体重时,ALT活性变化与对照组相比差异极显著(P<0.01)。表明在急性酒精性肝损伤模型中,GSTA1的含量变化在肝损伤早期就可检测出来,作为肝损伤标记物,GSTA1比ALT更敏感。
基金Supported by the National Natural Science Foundation of China(31472241)the Application Technology Research and Development Projects in Heilongjiang Province of China(PC13S03)
文摘The aim of the study was to investigate the hepatoprotective effects of Folium syringae(FS) extracts against ethanolinduced acute liver injury. Mice and primary hepatocytes were pretreated with FS extracts at different dosages before ethanol administration. Transaminases, glutathione S-transferase A1 level and hepatic biochemical indices(malondialdehyde, superoxide dismutase, glutathione and glutathione peroxidase) were determined. Pretreatment with FS extracts significantly inhibited the damage caused by ethanol and the hepatoprotective effects of FS were almost similar to Silymarin that was used to treat alcoholic liver injury. GSTA1 contents in all the FS extract-treated groups were significantly different from those in the ethanol-induced acute liver injury model group(p<0.01), and similar trends were observed in transaminases and hepatic indices level both in vitro and in vivo. The results showed that FS extracts had hepatoprotective effects against ethanol-induced injury. Those effects might be related to the enhancement of antioxidant capacity of liver cells, and FS extracts could reduce the release of liver GSTA1, which contributed to improve liver detoxification.
文摘AIM Human glutathione S-transferase A1 (GSTA1) is an important phase Ⅱ metabolizing enzyme involved in the metabolism of many therapeutic drugs and is responsible for the metabolic detoxification of numerous promutagens and procarcinogens. The genetic polymorphism of GSTA1 has important implications for drug efficacy and cancer susceptibility. In this study, we determined the distribution of GSTA1 genetic polymorphism in Mainland Chinese. And we also investigated whether there exists the potential phenotype alterations caused by the genetic polymorphism in human. METHODS Genomic DNA was ex-tracted from peripheral blood of 140 Chinese people and 16 liver tissues obtained from non-liverish patients who underwent partial hepatectomy. And then the genotypes of human GSTA1 gene were analyzed by polymerase chain reaction-restricted fragment length polymorphism (PCR-RFLP).
